Skip to main content
. Author manuscript; available in PMC: 2012 Apr 4.
Published in final edited form as: Cancer Res. 2009 Nov 10;69(23):8910–8917. doi: 10.1158/0008-5472.CAN-09-1543

Figure 4.

Figure 4

Tangeretin-cisplatin combination down-regulates p-Akt and its downstream substrates. The A2780/CP70 and 2008/C13 cells were treated with either 150 μM tangeretin or its vehicle for 24 hours and then treated for another 72 hours with cisplatin or its vehicle. The cellular proteins p-Akt, Akt, p-Bad, Bad, NFκB, p-GSK-3β and GSK-3β were determined by Western blot analysis.